HER2 Support Group Forums - View Single Post - Dr. Slamon describes results of genomic seqncng to determine who benefits from adding

Lani · 06-06-2015, 09:01 PM

everolimus (an mTor inhibitor which ffeecets the PI3k pathway) to herceptin in Stage IV patients

http://meetinglibrary.asco.org/content/112020?media=vm

06-06-2015, 09:01 PM	#1
Lani Senior Member Join Date: Mar 2006 Posts: 4,778	Dr. Slamon describes results of genomic seqncng to determine who benefits from adding everolimus (an mTor inhibitor which ffeecets the PI3k pathway) to herceptin in Stage IV patients http://meetinglibrary.asco.org/content/112020?media=vm